No Data
No Data
Optimistic Investors Push Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349) Shares Up 51% But Growth Is Lacking
shanghai fudan-zhangjiang bio-pharmaceutical co. ltd. (01349.HK) plans to hold a board of directors meeting on October 25th to approve the third quarter performance.
Glory Union October 14th | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) announced that a board of directors meeting will be held on October 25, 2024 (Friday) to review and approve (including) the unaudited performance of the company and its subsidiaries for the third quarter ending on October 14, 2024 and its release.
FUDANZHANGJIANG: NOTICE OF BOARD MEETING
Express News | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical - Entered Into Agreement With Shanghai Pudong Development Bank
shanghai fudan-zhangjiang bio-pharmaceutical co. ltd. (01349.HK) subscribed to 0.18 billion yuan structured deposit products
Oct. 8, Gelonhui| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) announced that the company recently entered into a structural deposit product agreement with Bank of China, agreeing to subscribe for RMB 0.18 billion yuan of structural deposit products with the proceeds from the A-share public offering temporarily idle.
Express News | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd - Subscription of Structured Deposit Product Under Bank of China
No Data
No Data